Uptown Research Institute

09/10/2026

Uptown Research Institute pledges our support for the CHRISCROSS Foundation's 6th Annual Fundraiser: Tailgate For Life. We strive to provide support for those in need of mental health services, as well as supporting the leadership within our community. September is National Su***de Prevention Month. Follow the link below to learn more.

6th Annual Tailgate for Life A Game Day with a Greater Purpose Join the CHRISCROSS Foundation for our annual fundraiser on Sunday, September 27, 2026,...

05/20/2026

Happy International Clinical Trials Day!

Today we recognize and give praise to those involved in the world of clinical research. Their passion, dedication, and hard work demonstrates what it takes to create a better world for those who need it most. The team at Uptown Research Institute remains focused on its mission of bringing science to practice and providing support to its community both locally and at large. We also recognize the efforts and commitment of our clinical trial participants. Together, we make the world of research possible.

03/25/2026

03/25/2026

How can families support a loved one with mental illness who is incarcerated?

Navigating the Criminal Justice System: A NAMI resource for people with mental illness and their families provides information to help families understand their role, communicate effectively, and support access to mental health care during incarceration and beyond.

Learn more at nami.org/CJGuide

03/13/2026

03/14/2024

Last week, the company MindMed announced the 12-week results from its Phase 2b study of MM120 (L*D D-Tartrate) in individuals with generalized anxiety disorder.

The results demonstrated that a single dose produced a clinical response in 65% of participants, with 48% of participants achieving clinical remission of symptoms. Importantly, these improvements lasted until the end of the 12-week study.

Based on these results, the FDA has granted Breakthrough Therapy Designation to MM120. This expedited review process is granted to drugs for which preliminary evidence has shown substantial improvement over existing therapies.

Uptown Research Institute is honored to have participated as a site for this Phase 2b study.

See the original press release here: https://ir.mindmed.co/news-events/press-releases/detail/137/mindmed-receives-fda-breakthrough-therapy-designation-and-announces-positive-12-week-durability-data-from-phase-2b-study-of-mm120-for-generalized-anxiety-disorder

06/01/2023

June is Alzheimer's and Brain Awareness Month

Get information and resources for Alzheimer's and other dementias from the Alzheimer's Association.

05/19/2023

Uptown Research Institute is passionate about making our research trials equitable and accessible for all. On Clinical Trials day, we send an overwhelming thank you to our team and those who participate in our studies!

Uptown Research is currently enrolling for clinical research trials for depression, anxiety, OCD, and schizophrenia. Interested in learning more? Call our recruitment manager at 773.989.8313 x116 to see if you qualify.